WEBSITE REDESIGN COMING SOON!

BOOST YOUR PATIENT'S OVERALL HEALTH

Hyperbaric Oxygen Therapy (HBOT) is a non-invasive treatment that delivers 100% oxygen at higher-than-atmospheric pressure inside a pressurized chamber. This increases plasma oxygen concentration and enhances oxygen delivery to hypoxic or metabolically stressed tissues. HBOT is increasingly applied within functional neurology to support neuroplasticity, reduce neuroinflammation, and accelerate recovery in patients with neurological and systemic conditions such as:

• Neurological recovery

• Chronic inflammatory or ischemic conditions: patients with persistent hypoxia or poor healing

• Neurodegenerative patients

• Complex chronic illness

HOW IT WORKS

• Increased Oxygen Partial Pressure: Patients breathe pure oxygen at pressures typically between 1.3–2.0 ATA (atmospheres absolute).

• Enhanced Oxygen Dissolution: Plasma oxygen content rises significantly, bypassing limitations of hemoglobin saturation.

• Physiological Effects:

• Promotes mitochondrial efficiency and ATP production

• Reduces oxidative stress and neuroinflammation

• Enhances stem cell mobilization and angiogenesis

• Improves microcirculation and tissue perfusion

• Modulates the autonomic nervous system (ANS)

  FEATURES AND BENEFITS

FDA-approved indications (U.S.):

• Air/gas embolism

• Carbon monoxide poisoning

• Decompression sickness

• Non-healing diabetic wounds

• Radiation injury (osteoradionecrosis, cystitis, proctitis)

• Severe anemia, thermal burns, and certain infections

Functional neurology and emerging uses (off-label but supported by clinical studies):

• Traumatic brain injury (TBI) & concussion – improved cognitive recovery, decreased post-concussive symptoms

• Stroke rehabilitation – neuroplasticity support, functional gains in chronic stroke patients

• Neurodegenerative disorders (Parkinson’s, Alzheimer’s, mild cognitive impairment) – potential neuroprotective effects

• Chronic fatigue syndrome & fibromyalgia – reduced pain, improved energy regulation

• Autism spectrum disorder (ASD) – emerging evidence for behavioral and cognitive improvements

• Multiple sclerosis (MS) – reported reduction in inflammation and fatigue

​